Médico Adjunto en el Departamento de Medicina Interna Servicio de Oncología Médica del Hospital Universitario Nuestra Señora de Candelaria (Tenerife)

Jefe de Sección del Servicio de Oncología Médica del Hospital Universitario Nuestra Señora de Candelaria

Médico Adjunto del Servicio de Oncología Médica del Hospital Universitario Nuestra Señora de Candelaria

Medico Residente Hospital Universitario Nuestra Señora de Candelaria

Doctor por la Universidad de La Laguna con la tesis Estudio epidemiológico y aspectos clínicos de presentación del cáncer de mama en la provincia de santa cruz de Tenerife

Estancia en el departamento de Medicina y Unidad de Trasplante de Médula Ósea, de la Universidad de Tubinga (Alemania),

Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy Biomedicines, Vol. 12, Núm. 9

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention BMC Neuroscience, Vol. 25, Núm1.

AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches Journal of Histochemistry and Cytochemistry, Vol. 70, Núm. 1, pp. 9-16

FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats Cells, Vol. 11, Núm. 9, pp. 1585

FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats Cells, Vol. 11, Núm. 9, pp. 1585

Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment Biomedicines, Vol. 10, Núm. 6, pp. 1271

Treatment of established chemotherapy-induced peripheral neuropathy: Basic science and animal models

Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy: A MASCC Book (Springer), pp. 137-153

Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview Supportive Care in Cancer, Vol. 27, Núm. 10, pp. 3729-3737

IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment

Whole-exome sequencing identifies somatic mutations associated with mortality in metastatic clear cell kidney carcinoma Frontiers in Genetics, Vol. 10, Núm. MAY

Alterations in IQGAP1 expression and localization in colorectal carcinoma and liver metastases following oxaliplatin-based chemotherapy Oncology Letters, Vol. 14, Núm. 3, pp. 2621-2628

Commitment of scaffold proteins in the onco-biology of human colorectal cancer and liver metastases after oxaliplatin-based chemotherapy International Journal of Molecular Sciences, Vol. 18, Núm. 4

IQGAP1 in podosomes/invadosomes is involved in the progression of glioblastoma multiforme depending on the tumor status International Journal of Molecular Sciences, Vol. 18, Núm. 1

Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry PLoS ONE, Vol. 12, Núm. 5

Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group Cancer, Vol. 123, Núm. 19, pp. 3709-3716

The Na, K-ATPase β-subunit isoforms expression in glioblastoma multiforme: Moonlighting rolesInternational Journal of Molecular Sciences, Vol. 18, Núm. 11

Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy Oncology Letters, Vol. 12, Núm. 2, pp. 1315-1322

Na,K-ATPase isozymes in colorectal cancer and liver metastases Frontiers in Physiology, Vol. 7, Núm. JAN

Differential transcriptome profile of peripheral white cells to identify biomarkers involved in oxaliplatin induced neuropathy Journal of Personalized Medicine, Vol. 4, Núm. 2, pp. 282-296

Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas: A case report Oncology Letters, Vol. 5, Núm. 3, pp. 969-971